West Pharmaceutical Services Change in AP remained flat by 0.0% to $4.48M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 517.2%, from $725.00K to $4.48M. Over 4 years (FY 2021 to FY 2025), Change in AP shows relatively stable performance with a 1.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase is generally positive for cash flow, as it allows the company to retain cash longer, provided it does not damage supplier relationships.
This measures the change in the amount the company owes to its suppliers and vendors for goods and services received. An...
Standard metric; companies often aim to optimize payment terms to maximize cash availability.
change_in_accounts_payable| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $16.80M | -$2.80M | $4.40M | $2.90M | $17.90M |
| YoY Change | — | -116.7% | +257.1% | -34.1% | +517.2% |